Venous and arterial thrombosis in COVID-19: An updated narrative review

Venous and arterial thrombosis in COVID-19: An updated narrative review

Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted to the intensive care unit (ICU) are at high risk of morbidity and mortality. Several observational studies have described hemostatic derangements and thrombotic complications in patients with COVID-19. The a...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Zainab Al Duhailib, Simon Oczkowski, Kamil Polok, Jakub Fronczek, Wojciech Szczeklik, Joshua Piticaru, Manoj J. Mammen, Fayez Alshamsi, John Eikelboom, Emilie Belley-Cote, Waleed Alhazzani
التنسيق:	مقال
اللغة:	English
منشور في:	Elsevier 2022-06-01
سلاسل:	Journal of Infection and Public Health
الموضوعات:	Anticoagulation COVID-19 Thrombosis Venous thromboembolism prophylaxis Critically ill D-dimer level
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S187603412200123X

مواد مشابهة

Risk Factors and Clinical Significance of D-Dimer in the Development of Postoperative Venous Thrombosis in Patients with Lung Tumor
حسب: Wang P, وآخرون
منشور في: (2020-06-01)

Increased Prevalence of Elevated D-Dimer Levels in Patients on Direct Oral Anticoagulants: Results of a Large Retrospective Study
حسب: Sara Reda, وآخرون
منشور في: (2022-03-01)

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results
حسب: Gualtiero Palareti, وآخرون
منشور في: (2022-03-01)

Optimal duration of anticoagulant therapy in patients with venous thromboembolism
حسب: Gualtiero Palareti
منشور في: (2018-09-01)

A Systematic Review on the Use of Aspirin in the Prevention of Deep Vein Thrombosis in Major Elective Lower Limb Orthopedic Surgery: An Update from the Past 3 Years
حسب: Dylan A. Mistry, وآخرون
منشور في: (2017-10-01)

Thromboembolism in Arthroplasty: Compliance to Prophylaxis
حسب: Leandra Marla Aires Travassos Viana, وآخرون
منشور في: (2021-12-01)

Venous thromboembolism in COVID 19 infection: Prevalence and practice of prophylaxis - A narrative
حسب: U Vasudeva Rao, وآخرون
منشور في: (2021-01-01)

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database
حسب: Miguel Pisani, وآخرون
منشور في: (2022-10-01)

Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement
حسب: Alpesh N. Amin, وآخرون
منشور في: (2011-09-01)

Renal Vein Thrombosis in Idiopathic Thrombocytopenic Purpura
حسب: Subodh Kumar Das, وآخرون
منشور في: (2020-03-01)

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
حسب: Ciuculete Denisa-Corina, وآخرون
منشور في: (2021-09-01)

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider
حسب: Daria Solari, وآخرون
منشور في: (2021-01-01)

Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery
حسب: Taishi Hata, وآخرون
منشور في: (2019-09-01)

New knowledge of prophylaxis and treatment about cancer-associated thrombosis
حسب: DING Yongjie, ZHANG Liu, LI Qingyun
منشور في: (2023-08-01)

Cancer and Thrombosis: New Treatments, New Challenges
حسب: Anders Erik Astrup Dahm
منشور في: (2021-06-01)

Risk factors for Venous Thromboembolism and clinical outcomes in adults with sickle cell disease
حسب: Brittany Scarpato, وآخرون
منشور في: (2022-03-01)

The importance of D-dimer test in the follow up of patients with deep venous thrombosis
حسب: Meral Ekim, وآخرون
منشور في: (2018-07-01)

CONTINUOUS THROMBOPROPHYLAXIS DURING SURGICAL TREATMENT OF PATIENT WITH POLYTRAUMA IN A MULTIDISCIPLINARY HOSPITAL (CASE REPORT)
حسب: I. G. Belenky, وآخرون
منشور في: (2017-07-01)

Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
حسب: Chelsea Matzko, وآخرون
منشور في: (2021-12-01)

PULMONARY EMBOLISM IN BREAST CANCER: ETIOLOGY, PATHOPHYSIOLOGY AND TREATMENT APPROACHES
حسب: I. D. Rozanov, وآخرون
منشور في: (2017-01-01)

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series
حسب: Nicholas L.J. Chornenki, وآخرون
منشور في: (2024-08-01)

Secondary thrombosis prevention practice patterns in pediatrics: Results of an international survey
حسب: Hope P. Wilson, وآخرون
منشور في: (2022-03-01)

Consensus document on anticoagulant management of deep vein thrombosis: A review
حسب: V S Bedi, وآخرون
منشور في: (2021-01-01)

Direct oral anticoagulants (DOACs) for postoperative venous thromboembolism prophylaxis in patients with gynecologic malignancies: A quality mini-review
حسب: Peter W. Ketch, وآخرون
منشور في: (2024-12-01)

ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST
حسب: Samir Arnaout, وآخرون
منشور في: (2011-05-01)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
حسب: Hyeon-Jeong Lee, وآخرون
منشور في: (2023-05-01)

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
حسب: Marcello Di Nisio, وآخرون
منشور في: (2024-05-01)

Deep vein thrombosis - the review
حسب: Karol Stępniak, وآخرون
منشور في: (2024-11-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
حسب: Sidrah Shah, وآخرون
منشور في: (2021-05-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
حسب: Sven R. Olson, وآخرون
منشور في: (2019-07-01)

New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
حسب: Mehrie H. Patel, وآخرون
منشور في: (2024-05-01)

Cerebral vein thrombosis as the initial presentation of acute promyelocytic leukemia (APML)
حسب: Fizza Zulfiqar, وآخرون
منشور في: (2025-01-01)

Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
حسب: Fleur H.J. Kaptein, وآخرون
منشور في: (2024-01-01)

Preoperative prevalence of deep vein thrombosis in patients scheduled to have surgery for degenerative musculoskeletal disorders
حسب: Keigo Sato, وآخرون
منشور في: (2021-06-01)

Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
حسب: Philip L. Mar, MD, PharmD, وآخرون
منشور في: (2020-03-01)

Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy
حسب: Roberts JC, وآخرون
منشور في: (2022-10-01)

Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
حسب: W. Anthony Hawkins, وآخرون
منشور في: (2021-10-01)

D-dimer: a useful tool in gauging optimal duration of oral anticoagulant therapy?
حسب: M. Silingardi, وآخرون
منشور في: (2013-05-01)

An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study
حسب: Fumihiro Ogawa, وآخرون
منشور في: (2021-04-01)

Prevalence, Risk Factors of Deep Venous Thrombosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Cross-sectional Study
حسب: P SPURTHY, وآخرون
منشور في: (2024-01-01)